Houston Methodist researchers have discovered that certain components of so-called “good” cholesterol — high-density lipoproteins (HDL) – may be associated with an increased prevalence of cardiovascular disease.
G1 Therapeutics and Pepper Bio Announce Ink Global License Agreement for Lerociclib
What You Should Know: – G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, and Pepper Bio, the world’s first transomics drug discovery and development
April 30, 2024